Bellantani, S, Saccoccio, G, Masutti, F, Croce, LS, Brandi, G, Sasso, F, Cristanini, G & Tiribelli, CPrevalence and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med (2000) 132, 112–117.
Berger, JJ & Barnard, RJEffect of diet on fat cell size and hormone-sensitive lipase activity. J Appl Physiol (1999) 87, 227–232.
Brasaemle, DL, Rubin, B, Harten, IA, Gruia-Gray, J, Kimmel, AR & Londos, CPerilipin A increases triacylglycerol storage by decreasing the rate of triacyglycerol hydrolysis. J Biol Chem (2000) 275, 38486–38493.
Chitturi, S & Farrell, GCEtiopathogenesis of non-alcoholic steatohepatitis. Semin Liver Dis (2001) 21, 27–41.
Enevoldsen, LH, Stallknecht, B, Fluckey, JD & Galbo, CEffect of exercise training on in vivo lipolysis in intra-abdominal adipose tissue in rats. Am J Physiol Endocrinol Metab (2000) 279, E585–E592.
Festi, D, Colecchia, A, Sacco, T, Bondi, M, Roda, E & Marchesini, GHepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev (2004) 5, 27–42.
Frayn, KNVisceral fat and insulin resistance–causative or correlative?. Br J Nutr (2000) 83, s71–s77.
Frayn, KN & Maycock, PFSkeletal muscle triacylglycerol in the rat: methods for sampling and measurement and studies of biological variability. J Lipid Res (1980) 21, 139–144.
Gauthier, M-S, Couturier, K, Charbonneau, A & Lavoie, J-MEffects of introducing physical training in the course of a 16-week high-fat diet regimen on hepatic steatosis, adipose tissue fat accumulation, and plasma lipid profile. Int J Obes (2004) 28, 1064–1071.
Gauthier, M-S, Couturier, K, Latour, JG & Lavoie, J-MConcurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol (2003) 94, 217–2134.
Gauthier, M-S, Favier, R & Lavoie, J-MTime course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr (2006) 95, 273–281.
Greenberg, A.S, Egan, JJ, Wek, SA, Garty, NB, Blanchette-Mackie, EJ & Londos, CPerilipin, a major hormonally regulated adipocyte specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem (1991) 266, 11341–11346.
Havel, RJ & Hamilton, RLHepatic catabolism of remnant lipoproteins: where the action is. Arterioscler Thromb Vasc Biol (2004) 24, 213–215.
James, O & Day, CNon-alcoholic steatohepatitis. Another disease of affluence. Lancet (1999) 353, 1634–1636.
Kraegen, EW, Clark, PW, Jenkins, AB, Daley, EA, Chisholm, DJ & Storlien, LHDevelopment of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes (1991) 40, 1397–1403.
Large, V & Arner, PRegulation of lypolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab (1998) 24, 409–418.
Lewis, GF, Carpentier, A, Adeli, K & Giacca, ADisordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Rev (2002) 23, 201–229.
Londos, C, Brasaemle, DJ, Schultz, CJ, Segrest, JP & Kimmel, ARPerilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol (1999) 10, 51–58.
Londos, C, Sztalryd, C, Tansey, JT & Kimmel, ARRole of PAT proteins in lipid metabolism. Biochimie (2005) 87, 45–49.
Marchesini, G, Brizi, M, Bianchi, G, Tomassetti, S, Bugianesi, E, Lenzi, M, McCullogh, AJ, Natale, S, Forlani, G & Melchionda, NNonalcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes (2001) 50, 1844–1850.
Miles, JM, Park, YS, Walewicz, D, Russell-Lopez, C, Windsor, S, Isley, WL, Coppack, SW & Harris, WSSystemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes (2004) 53, 521–527.
Mottagui-Tabar, S, Ryden, M, Lofgren, P, Faulds, G, Hoffstedt, J, Brookes, AJ, Andersson, I & Arner, PEvidence for an important role of perilipin in the regulation of human adipocyte lipolysis. Diabetologia (2003) 46, 789–797.
Must, A, Spadano, J, Coakley, EH, Field, AE, Colditz, G & Dietz, WHThe disease burden associated with overweight and obesity. JAMA (1999) 282, 1523–1529.
Riemens, SC, Sluiter, WJ & Dullaart, RPEnhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and type 2 diabetes mellitus. Diabetologia (2000) 43, 416–426.
Rodbell, MMetabolism of isolated fat cells I. Effects of hormones on glucose metabolism and lipolysis. Diabetologia (2000) 43, 416–426.
Rodbell, MMetabolism of isolated fat cells I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem (1964) 239, 375–380.
Samuel, VT, Liu, Z-X, Qu, X, Elder, BD, Bilz, S, Belfroy, D, Romanelli, AJ & Shulman, GIMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem (2004) 279, 32345–32353.
Scheen, AJ & Luyckx, FHObesity and liver disease. Best Pract
Res Clin Endocrinol Met (2002) 16, 703–716.
Sniderman, AD, Cianflone, K, Arner, P, Summers, LKM & Frayn, KNThe adipocyte, fatty acid trapping, and atherogenesis. Arterioscler Thromb Vasc Biol (1998) 18, 147–151.
Sztalryd, C, Xu, G, Dorward, H, Tansey, JT, Contreras, JA, Kimmel, AR & Londos, CPerilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J Cell Biol (2003) 161, 1011–1012.
Wang, Y, Sullivan, S, Trujillo, M, Lee, M-J, Schneider, S, Brolin, RE, Kang, YH, Werber, Y, Greenberg, AS & Fried, SKPerilipin expression in human adipose tissues: effects of severe obesity gender, and depot. Obes Res (2003) 11, 930–936.